Correlation Between Achilles Therapeutics and Nektar Therapeutics

Can any of the company-specific risk be diversified away by investing in both Achilles Therapeutics and Nektar Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Achilles Therapeutics and Nektar Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Achilles Therapeutics PLC and Nektar Therapeutics, you can compare the effects of market volatilities on Achilles Therapeutics and Nektar Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Achilles Therapeutics with a short position of Nektar Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Achilles Therapeutics and Nektar Therapeutics.

Diversification Opportunities for Achilles Therapeutics and Nektar Therapeutics

-0.21

Correlation Coefficient

Achilles Therapeutics  Nektar Therapeutics

Very good diversification

The 3 months correlation between Achilles and Nektar is -0.21. Overlapping area represents the amount of risk that can be diversified away by holding Achilles Therapeutics PLC and Nektar Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nektar Therapeutics and Achilles Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Achilles Therapeutics PLC are associated (or correlated) with Nektar Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nektar Therapeutics has no effect on the direction of Achilles Therapeutics i.e., Achilles Therapeutics and Nektar Therapeutics go up and down completely randomly.

Pair Corralation between Achilles Therapeutics and Nektar Therapeutics

Given the investment horizon of 90 days Achilles Therapeutics PLC is expected to generate 0.64 times more return on investment than Nektar Therapeutics. However, Achilles Therapeutics PLC is 1.57 times less risky than Nektar Therapeutics. It trades about 0.2 of its potential returns per unit of risk. Nektar Therapeutics is currently generating about 0.01 per unit of risk. If you would invest  98.00  in Achilles Therapeutics PLC on December 21, 2024 and sell it today you would earn a total of  50.00  from holding Achilles Therapeutics PLC or generate 51.02% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Achilles Therapeutics PLC  vs.  Nektar Therapeutics

Achilles Therapeutics PLC

Risk-Adjusted Performance

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Achilles Therapeutics PLC are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. Despite quite weak technical indicators, Achilles Therapeutics disclosed solid returns over the last few months and may actually be approaching a breakup point.

Nektar Therapeutics

Risk-Adjusted Performance

Very Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Nektar Therapeutics are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Even with relatively invariable basic indicators, Nektar Therapeutics is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.

Pair Trading with Achilles Therapeutics and Nektar Therapeutics

The main advantage of trading using opposite Achilles Therapeutics and Nektar Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Achilles Therapeutics position performs unexpectedly, Nektar Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nektar Therapeutics will offset losses from the drop in Nektar Therapeutics' long position.

The idea behind Achilles Therapeutics PLC and Nektar Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.